1. Cothern, C.R., Coniglio, W.A., and Marcus, W.L. (1984). Techniques for the assessment of the carcinogenic risks to the U.S. population due to exposure from selected volatile organic compounds from drinking water via ingestion, inhalation and dermal routes. Washington, D.C.: EPA Office of Drinking Water, PB 84–213941.
2.
2. Shehata, A.T. (1985). A multi-route exposure assessment of chemically contaminated drinking water. Toxicol. Ind. Health4, 277–298.
3.
3. Andelman, J.B. (1985). Human exposure to volatile halogenated organic chemicals in indoor and outdoor air. Environ. Health Perspect.62, 313–318.
4.
4. Andelman, J.B. (1985). Inhalation exposure in the home to volatile organic contaminants of drinking water. Sci Total Environ.47, 443–460.
5.
5. Mckone, T.E. (1987). Human exposure to volatile organic compounds in household tap water: The indoor inhalation pathway. Environ. Sci. Technol.21, 1194–1201.
6.
6. Vanderslice, R. (1988). USEPA Office of Drinking Water, personal communication.
7.
7. Environ Report (1988). Washington, D.C.
8.
8. Brown, H.S., Bishop, D.R., and Rowan, C.A. (1984). The role of skin absorption as a route of exposure for volatile organic compounds (VOCs) in drinking water. Am. J. Public Health74, 479–484.
9.
9. Dutkiewicz, T., and Tyras, H. (1967). A study of the skin absorption of ethylbenzene in man. Br. J. Ind. Med.24, 330–332.
10.
10. Dutkiewicz, T., and Tyras, H. (1968). Skin absorption of toluene, styrene and xylene by man. Br. J. Ind Med24, 243.
11.
11. Guy, R.H., Hadgraft, J., and Maibach, H.I. (1982). A pharmacokinetic model for percutaneous absorption. Int. J. Pharmaceut.11, 119–129.
12.
12. Guy, R.H., Hadgraft, J., and Maibach, H.I. (1985). Percutaneous absorption in man: A kinetic approach. Toxicol Appl Pharmacol78, 123–129.
13.
13. Guy, R.H., and Hadgraft, J. (1985). Transdermal drug delivery: A simplified pharmacokinetic approach. Int. J. Pharmaceut.24, 267–274.
14.
14. Marzulli, F.N., and Maibach, H.J. (eds). (1977). Advances in Modern Toxicology, Volume 4, Dermatotoxicology and Pharmacology. New York: John Wiley.
15.
15. Blank, I.H., and Scheuplein, R.J. (1969). Transport into and within the skin. Br. J. Dermatol.81 (Suppl 4), 4–10.
16.
16. Blank, I.H., and Mcauliffe, D.J. (1985). Penetration of benzene through human skin. J. Invest. Dermatol.85, 522–526.
17.
17. Hattis, D., Tuler, S., Finkelstein, L., and Luo, Z. (1986). A pharmacokinetic/mechanism-based analysis of the carcinogenic risk of perchloroethylene. CTPID Publication 86–7, Cambridge, MA: Massachusetts Institute of Technology.
18.
18. Roberts, M.S., Triggs, E.J., and Anderson, R.A. (1975). Permeability of solutes through biological membranes measured by a desorption technique. Nature257, 225–227.
19.
19. Scheuplein, R.J. (1965). Mechanism of percutaneous absorption. I. Routes of penetration and influence of solubility. J. Invest. Dermatol.45, 334–345.
20.
20. Guy, R.H., and Maibach, H.I. (1984). Correction factors for determining body exposure from forearm percutaneous absorption data. J. Appl Toxicol4(1), 26–28.
21.
21. Wade, O.L., and Bishop, J.M. (1962). Cardiac Output and Regional Blood Flow. Philadelphia: F.A. Davis.
22.
22. Hagemann, J. (1979). Cancer Risks at Work. Colloquium on Occupational Medicine, 19th Annual Conference of German Occupational Medicine Society.
23.
23. Veulemans, H., and Masschlein, R. (1978). Experimental human exposure to toluene. Int. Arch. Occup. Health42, 105–117.
24.
24. Lof, A., Lundgren, E., and Byfalt Nordquist, M. (1986). Kinetics of styrene in workers from plastics industry after controlled exposure: A comparison with subjects not previously exposed. Br. J. Ind. Med.43, 537–543.
